124 related articles for article (PubMed ID: 34306405)
21. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma.
Chang CC; Yang YJ; Li YJ; Chen ST; Lin BR; Wu TS; Lin SK; Kuo MY; Tan CT
Oral Oncol; 2013 Sep; 49(9):923-931. PubMed ID: 23602254
[TBL] [Abstract][Full Text] [Related]
22. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
23. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
[TBL] [Abstract][Full Text] [Related]
24. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
25. Hsa_circ_0001649 restrains gastric carcinoma growth and metastasis by downregulation of miR-20a.
Sun H; Wang Q; Yuan G; Quan J; Dong D; Lun Y; Sun B
J Clin Lab Anal; 2020 Jun; 34(6):e23235. PubMed ID: 32212290
[TBL] [Abstract][Full Text] [Related]
26. Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
Zhuang K; Han K; Tang H; Yin X; Zhang J; Zhang X; Zhang L
Med Sci Monit; 2016 Feb; 22():356-61. PubMed ID: 26835790
[TBL] [Abstract][Full Text] [Related]
27. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
28. The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer.
Zhao L; Zhao Y; He Y; Li Q; Mao Y
Cell Signal; 2018 Nov; 51():152-165. PubMed ID: 30092355
[TBL] [Abstract][Full Text] [Related]
29. MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis.
Huang D; Peng Y; Ma K; Deng X; Tang L; Jing D; Shao Z
BMC Cancer; 2018 Nov; 18(1):1189. PubMed ID: 30497428
[TBL] [Abstract][Full Text] [Related]
30. miR-210 is a Serological Biomarker for Predicting Recurrence and Prognosis of Colon Carcinoma Patients with Liver Metastases After Radiofrequency Ablation Treatment.
Zhang Y; Zhou YM; Zhang ZJ; Li X
Cancer Manag Res; 2020; 12():9077-9085. PubMed ID: 33061602
[TBL] [Abstract][Full Text] [Related]
31. Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer.
Jing LL; Mo XM
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1516-20. PubMed ID: 27160123
[TBL] [Abstract][Full Text] [Related]
32. miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer.
Xu Y; Sun J; Xu J; Li Q; Guo Y; Zhang Q
Gastroenterol Res Pract; 2012; 2012():640168. PubMed ID: 22792096
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract][Full Text] [Related]
34. Expression levels and clinical significance of miR-203 and miR-133b in laryngeal carcinoma.
Zhao N; Liu H; Zhang A; Wang M
Oncol Lett; 2020 Nov; 20(5):213. PubMed ID: 32963619
[TBL] [Abstract][Full Text] [Related]
35. Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer.
Bai SY; Ji R; Wei H; Guo QH; Yuan H; Chen ZF; Wang YP; Liu Z; Yang XY; Zhou YN
Turk J Gastroenterol; 2019 May; 30(5):415-419. PubMed ID: 31060996
[TBL] [Abstract][Full Text] [Related]
36. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
37. Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer.
Feng R; Beeharry MK; Lu S; Sah BK; Yuan F; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 22(1):119-126. PubMed ID: 29562500
[TBL] [Abstract][Full Text] [Related]
38. The downregulation of miR-519a predicts poor prognosis and contributes to tumor progression in gastric cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Int J Clin Exp Pathol; 2019; 12(7):2496-2505. PubMed ID: 31934076
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
[TBL] [Abstract][Full Text] [Related]
40. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
